1. Chemoresistance Mechanisms in Non-Small Cell Lung Cancer—Opportunities for Drug Repurposing
   Rajdeep Kaur et al, 2023, Applied Biochemistry and Biotechnology CrossRef
2. PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma
   Kun Wu et al, 2021, Frontiers in Oncology CrossRef
3. The Role of the Urokinase-Type Plasminogen Activator System In Tumor Progression
   E. V. Kugaevskaya et al, 2019, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef
4. Multicompartment duct platform to study epithelial–endothelial crosstalk associated with lung adenocarcinoma
   Keith A. Gagnon et al, 2024, APL Bioengineering CrossRef
5. The Association between Plasma Levels of Intact and Cleaved uPAR Levels and the Risk of Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer
   Hein Vincent Stroomberg et al, 2020, Diagnostics CrossRef
6. Sustained postoperative plasma elevations of plasminogen activator inhibitor‑1 following minimally invasive colorectal cancer resection
   H.M.C. Kumara et al, 2021, Molecular and Clinical Oncology CrossRef
7. Human antibody VH domains targeting uPAR as candidate therapeutics for cancers
   Xiaojie Chu et al, 2023, Frontiers in Oncology CrossRef
8. The urokinase-type plasminogen activator system and its role in tumor progression
   E.V. Kugaevskaya et al, 2018, Biomeditsinskaya Khimiya CrossRef